In addition to R-2HG, other FTO inhibitors (or m6A activators), such as Meclofenamic acid, N-(5-Chloro-2,4-dihydroxyphenyl)-1-phenylcyclobutanecarboxamide, as well as some small molecules, also have potential in anti-muscular atrophy effect [17, 79, 80], and are worth verifying in the future. This evidence concerns the gene FTO and muscular atrophy.